Barclays CEO diagnosed with non-Hodgkin lymphoma

0
20

By Joe Hoppe


Barclays PLC said Monday that Chief Executive Officer C.S. Venkatakrishnan has been diagnosed with non-Hodgkin lymphoma, with treatment expected to last 12 to 16 weeks.

The FTSE 100-listed bank said the cancer has been detected early and the prognosis is good. Mr. Venkatakrishnan will continue to actively manage the company during the treatment period.


Write to Joe Hoppe at joseph.hoppe@wsj.com


This article was originally published by Marketwatch.com. Read the original article here.

Previous articleMarket Extra: Is the market bottom in? 5 reasons U.S. stocks could continue to suffer heading into next year.
Next articleMarket Snapshot: U.S. stock futures slide as China unrest raises growth fears

LEAVE A REPLY

Please enter your comment!
Please enter your name here